Market Movers

Elevance Health, Inc.’s Stock Price Dips to $521.41, Marking a 4.14% Decrease: An In-depth Analysis

Elevance Health, Inc. (ELV)

521.41 USD -22.53 (-4.14%) Volume: 1.53M

Explore Elevance Health, Inc.’s stock price performance, currently standing at 521.41 USD, experiencing a decrease of -4.14% this trading session with a trading volume of 1.53M. Despite this drop, the stock boasts a positive year-to-date percentage change of +10.57%.


Latest developments on Elevance Health, Inc.

Elevance Health, Inc. (NYSE:ELV) has been making waves in the stock market recently, with CreativeOne Wealth LLC acquiring 285 shares and Wells Fargo & Company MN acquiring 14762 shares. Despite experiencing losses on the day, the company’s stock has outperformed competitors, reaching a new 12-month high at $550.34. In addition, Elevance Health recently announced its participation in Bernstein’s 40th Annual Strategic Decisions Conference, showcasing its strong presence in the industry. AM Best has also assigned issue credit ratings to the company’s new senior unsecured notes, indicating a positive outlook for Elevance Health’s future.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars